Funding Details
- Awarder
- Inbox
- Date Award
- September 17, 2019
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
-
$50,000,000
Company Info
- Founding Year
- 2017
- Founders
- Alan Russell, Ph.D., Peter Thompson, M.D., Badreddin Edris, Ph.D.
- Company Description
- Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
- Market
- Musculoskeletal diseases
- Location
-
Boulder,
Colorado,
USA
- Coinvestors
- CureDuchenne Ventures, Deerfield Management Company, L.P., New Leaf Venture Partners, Novo Holdings, OrbiMed Advisors, US Venture Partners
Links